This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Data Driven, Hybrid & Full Decentralized Clinical Trials
Mark Your Calendar for Data Driven, Hybrid and Full Decentralized Clinical Trials 2024!
In-Person Event: April 16 - 17, 2024Hilton Philadelphia at Penn's Landing, Philadelphia

Sarah Valentine
Partnerships Lead, Life Sciences at Digital Medicine Society (DiMe)
Speaker

Profile

Sarah Valentine leads partnerships across life sciences at the Digital Medicine Society (DiMe). In her role, she thinks critically about the challenges we face in drug development and commercialization to drive strategy, prioritization, and concept development across areas of unmet need where there's an opportunity at the intersection of healthcare and technology to deliver unprecedented value to patients and other stakeholders across our industry. She convenes teams of interdisciplinary thought leaders and subject matter experts to tackle some of the biggest challenges we face as a field in order to advance the ethical, effective, equitable, and safe use of digital medicine to redefine healthcare and improve lives. Prior to her role at DiMe, Sarah was a digital implementation lead at Eli Lilly & Company, where she led efforts at the intersection of clinical development and digital health to leverage innovative digital technologies including digital measures, combination products, and other DDTs in clinical research.

Agenda Sessions

  • Chairperson's Opening Remarks: Technology Innovation & Data Management for Clinical Trials

    9:45am
  • Decentralised Trials for Different Therapeutic Areas – Pros and Cons

    2:15pm